BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6093595)

  • 21. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
    Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.
    Balwierczak JL; Grupp IL; Grupp G; Schwartz A
    J Pharmacol Exp Ther; 1986 Apr; 237(1):40-8. PubMed ID: 2937911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ; Murphy KM; Snyder SH
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peripheral, high affinity benzodiazepine binding site is not coupled to the cardiac Ca2+ channel.
    Holck M; Osterrieder W
    Eur J Pharmacol; 1985 Dec; 118(3):293-301. PubMed ID: 2417868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
    Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
    Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
    Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
    Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
    Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ
    Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem.
    DePover A; Matlib MA; Lee SW; Dubé GP; Grupp IL; Grupp G; Schwartz A
    Biochem Biophys Res Commun; 1982 Sep; 108(1):110-7. PubMed ID: 6293474
    [No Abstract]   [Full Text] [Related]  

  • 29. Ontogenic appearance of Ca2+ channels characterized as binding sites for nitrendipine during development of nervous, skeletal and cardiac muscle systems in the rat.
    Kazazoglou T; Schmid A; Renaud JF; Lazdunski M
    FEBS Lett; 1983 Nov; 164(1):75-9. PubMed ID: 6317445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane.
    Rogart RB; deBruyn Kops A; Dzau VJ
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7452-6. PubMed ID: 2429306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical and pharmacological approaches to the definition and quantitation of calcium channels.
    Gengo PJ; Luchowski E; Rampe DE; Rutledge A; Triggle AM; Triggle DJ; Janis RA
    Cold Spring Harb Symp Quant Biol; 1983; 48 Pt 1():279-85. PubMed ID: 6327161
    [No Abstract]   [Full Text] [Related]  

  • 32. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hoe 263, a new substance with calcium channel antagonistic activity.
    Lindner E; Ruppert D; Kaiser J
    Pharmacology; 1984; 29(3):165-72. PubMed ID: 6483963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diltiazem-like effect of thioridazine on the dihydropyridine binding site of the calcium channel of rat myocardial membranes.
    Thorgeirsson G; Rudolph SA
    Biochem Biophys Res Commun; 1984 Jun; 121(2):657-63. PubMed ID: 6329206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.
    Schwartz J; Velly J
    Br J Pharmacol; 1985 Feb; 84(2):511-5. PubMed ID: 3156649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between propranolol and calcium channel blockers in cardiac and vascular smooth muscle.
    Weishaar RE; Quade MM; Pugsley TA; Shih YH; Taylor DG
    J Mol Cell Cardiol; 1988 Oct; 20(10):897-903. PubMed ID: 3216400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of nitrendipine and Bay k 8644 binding to isolated canine heart sarcolemma with their pharmacological effects on the canine heart.
    Vaghy PL; Grupp IL; Grupp G; Balwierczak JL; Williams JS; Schwartz A
    Eur J Pharmacol; 1984 Jul; 102(2):373-4. PubMed ID: 6207033
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of metal cations and calmodulin antagonists on [3H] nitrendipine binding in smooth and cardiac muscle.
    Luchowski EM; Yousif F; Triggle DJ; Maurer SC; Sarmiento JG; Janis RA
    J Pharmacol Exp Ther; 1984 Sep; 230(3):607-13. PubMed ID: 6433001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of postnatal maturation on myocardial contractile responses to calcium antagonists and changes in contraction frequency.
    Artman M; Graham TP; Boucek RJ
    J Cardiovasc Pharmacol; 1985; 7(5):850-5. PubMed ID: 2413291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes.
    Gopalakrishnan V; Triggle CR
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1249-52. PubMed ID: 6498637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.